D

Duopharma Biotech Bhd
KLSE:DPHARMA

Watchlist Manager
Duopharma Biotech Bhd
KLSE:DPHARMA
Watchlist
Price: 1.23 MYR Market Closed
Market Cap: 1.2B MYR
Have any thoughts about
Duopharma Biotech Bhd?
Write Note

Wall Street
Price Targets

DPHARMA Price Targets Summary
Duopharma Biotech Bhd

Wall Street analysts forecast DPHARMA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DPHARMA is 1.49 MYR with a low forecast of 1.35 MYR and a high forecast of 1.63 MYR.

Lowest
Price Target
1.35 MYR
10% Upside
Average
Price Target
1.49 MYR
21% Upside
Highest
Price Target
1.63 MYR
32% Upside
Duopharma Biotech Bhd Competitors:
Price Targets
4540
Tsumura & Co
6% Upside
000739
Apeloa Pharmaceutical Co Ltd
22% Upside
DHG
Dhg Pharmaceutical Joint-Stock Co
5% Upside
INVA
Innoviva Inc
8% Downside
000999
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
20% Upside
PFIZER
Pfizer Ltd
16% Upside

Revenue
Forecast

Revenue Estimate
Duopharma Biotech Bhd

For the last 8 years the compound annual growth rate for Duopharma Biotech Bhd's revenue is 13%. The projected CAGR for the next 3 years is 8%.

13%
Past Growth
8%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Duopharma Biotech Bhd

For the last 8 years the compound annual growth rate for Duopharma Biotech Bhd's operating income is 6%. The projected CAGR for the next 3 years is 20%.

6%
Past Growth
20%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Duopharma Biotech Bhd

For the last 8 years the compound annual growth rate for Duopharma Biotech Bhd's net income is 5%. The projected CAGR for the next 3 years is 22%.

5%
Past Growth
22%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DPHARMA's stock price target?
Price Target
1.49 MYR

According to Wall Street analysts, the average 1-year price target for DPHARMA is 1.49 MYR with a low forecast of 1.35 MYR and a high forecast of 1.63 MYR.

What is Duopharma Biotech Bhd's Revenue forecast?
Projected CAGR
8%

For the last 8 years the compound annual growth rate for Duopharma Biotech Bhd's revenue is 13%. The projected CAGR for the next 3 years is 8%.

What is Duopharma Biotech Bhd's Operating Income forecast?
Projected CAGR
20%

For the last 8 years the compound annual growth rate for Duopharma Biotech Bhd's operating income is 6%. The projected CAGR for the next 3 years is 20%.

What is Duopharma Biotech Bhd's Net Income forecast?
Projected CAGR
22%

For the last 8 years the compound annual growth rate for Duopharma Biotech Bhd's net income is 5%. The projected CAGR for the next 3 years is 22%.

Back to Top